Cite
HARVARD Citation
Schindler, E. et al. (2017). A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients. CPT: pharmacometrics & systems pharmacology. pp. 373-382. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schindler, E. et al. (2017). A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients. CPT: pharmacometrics & systems pharmacology. pp. 373-382. [Online].